# First-In-Human PainCart Study for STR-324

> **NCT03430232** · PHASE1 · COMPLETED · sponsor: **Stragen France** · enrollment: 78 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Placebo
- **DRUG:** STR-324 Dose Level 1
- **DRUG:** STR-324 Dose Level 2
- **DRUG:** STR-324 Dose Level 3
- **DRUG:** STR-324 Dose Level 4
- **DRUG:** STR-324 Dose Level 5
- **DRUG:** STR-324 Dose Level 6
- **DRUG:** STR-324 Dose Level 7
- **DRUG:** STR-324 Dose Level 8
- **DRUG:** STR-324 Dose Level A
- **DRUG:** STR-324 Dose Level B
- **DRUG:** STR-324 Dose Level C
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03430232
- **Lead sponsor:** Stragen France
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-20
- **Primary completion:** 2018-11-07
- **Final completion:** 2018-11-07
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430232, "First-In-Human PainCart Study for STR-324". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03430232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*